The angiotensin II receptor blocker (ARB) telmisartan (Micardis) did not significantly improve walking performance in patients with lower-extremity peripheral artery disease (PAD) in a randomized ...

A new study found that peripheral neuropathy is linked to slow gait and impaired lower extremity performance in older adults with and without diabetes. Peripheral neuropathy is a progressive ...

Disparities in rates of peripheral diabetic neuropathy and lower extremity amputation exist in the United States. To investigate the factors linked to this disparity, we performed a systematic review ...

This review examines the current guidance and issues related to lipid optimization of patients with peripheral arterial disease (PAD). A narrative review that was published in the Annals of Vascular ...